Quantitative assessment of coronary microvascular function in patients with and without epicardial atherosclerosis
EuroIntervention 2010;5 939-945.
Narbeh Melikian1,2, BSc, MD, MRCP; Stephen Vercauteren1, MD; William F. Fearon3, MD; Thomas Cuisset1, MD; Philip A. MacCarthy4, MB BCh, PhD, FRCP; Giedrius Davidavicius1, MD; Wilbert Aarnoudse5, MD; Jozef Bartunek1, MD, PhD; Marc Vanderheyden1, MD, PhD; Eric Wyffels1, MD; William Wijns1, MD, PhD; Guy R. Heyndrickx1, MD, PhD; Nico H. J. Pijls5, MD, PhD; Bernard De Bruyne1*, MD, PhD
1. Cardiovascular Center, OLV Hospital, Aalst, Belgium; 2. Cardiology Department, King’s College London School of Medicine, London, United Kingdom; 3. Division of Cardiovascular Medicine, Stanford University Medical Center, Stanford, CA, USA; 4. Cardiolog
Aims: The influence of atherosclerosis and its risk factors on coronary microvascular function remain unclear as current methods of assessing microvascular function do not specifically test